Lung cancer accounts for an alarming human and economic burden in low-and middle-
income countries (LMICs). Recent landmark trials from high-income countries (HICs) by …

Abstract Background: On 31 December 2013, the US Preventive Services Task Force rated
low-dose computed tomography (LDCT) for lung cancer screening as level …

Background Lung cancer screening with low-dose computed tomography (LDCT) has been
shown to deliver appreciable reductions in mortality in high-risk patients. However, in an era …

Background Lung cancer is the leading cause of cancer death worldwide. Data on the
effectiveness of one-off low-dose CT (LDCT) in reducing lung cancer mortality and all-cause …

Low-dose computed tomography (LDCT) screening for lung cancer substantially reduces
mortality from lung cancer, as revealed in randomized controlled trials and meta-analyses …

Abstract The National Lung Screening Trial (NLST) has sparked new interest in the adoption
of lung cancer screening using low‐dose computed tomography (LDCT). If adopted at a …

Background Lung cancer is the most common cause of cancer‐related death in the world,
however lung cancer screening has not been implemented in most countries at a population …

Lung cancer is the leading cause of cancer death worldwide, comprising almost 20% of all
cancer deaths. The concept of screening for lung cancer using low-dose computed …

Importance Lung cancer is the leading cause of cancer-related death in the US. Objective To
review the evidence on screening for lung cancer with low-dose computed tomography …

A recent randomized trial showed that low-dose CT (LDCT) screening reduces lung cancer
mortality. Health care providers need an assessment of the national budget impact and cost …